| Name | Primaquine diphosphate |
| Synonyms | Primaquine Phosphate Primaquine diphosphate Primaquine bisphosphate PRIMAQUINEPHOSPHATE,USP N-(6-Methoxyquinolin-8-yl)pentane-1,4-diamine phosphoric acid 8-((4-amino-1-methylbutyl)amino)-6-methoxy-quinolin phosphate 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline diphosphate 4-pentanediamine, n(sup 4)-(6-methoxy-8-quinolinyl)- phosphate 8-(4-amino-1-methylbutylamino)-6-methoxyquinoline diphosphate salt Primaquine diphosphate salt, 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline diphosphate salt |
| CAS | 63-45-6 |
| EINECS | 200-560-8 |
| InChI | InChI=1/C15H21N3O.2H3O4P/c1-11(5-3-7-16)18-14-10-13(19-2)9-12-6-4-8-17-15(12)14;2*1-5(2,3)4/h4,6,8-11,18H,3,5,7,16H2,1-2H3;2*(H3,1,2,3,4) |
| Molecular Formula | C15H27N3O9P2 |
| Molar Mass | 455.34 |
| Melting Point | 205-206°C (dec.)(lit.) |
| Boling Point | 451.1°C at 760 mmHg |
| Flash Point | 226.6°C |
| Water Solubility | moderately soluble |
| Solubility | water: soluble50mg/mL, clear, orange to red |
| Vapor Presure | 2.5E-08mmHg at 25°C |
| Appearance | Orange powder |
| Merck | 13,7833 |
| BRN | 3812133 |
| Storage Condition | 2-8°C |
| Stability | Stable. Incompatible with strong oxidizing agents. |
| MDL | MFCD00013166 |
| Use | Antimalarial drugs for the control of Plasmodium vivax and Plasmodium vivax recurrences and falciparum malaria transmission |
| Hazard Symbols | T - Toxic![]() |
| Risk Codes | 25 - Toxic if swallowed |
| Safety Description | 45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
| UN IDs | UN 2811 6.1/PG 3 |
| WGK Germany | 3 |
| RTECS | VA9660000 |
| FLUKA BRAND F CODES | 10 |
| HS Code | 29334900 |
| Hazard Class | 6.1(b) |
| Packing Group | III |
| Reference Show more | 1. [IF=3.361] Lancheng Wang et al."Using dual exonucleases to finely distinguish structural adjustment of aptamers for small-molecule detection."Rsc Adv. 2021 Oct;11(52):32898-32903 |